Study of the therapeutic potential of an Akkermansia muciniphila-based products in subjects with an increased cardio-metabolic risk.

Project Information

Microbes4U

Grant agreement ID: 713547

DOI

10.3030/713547

Project closed

EC signature date 27 June 2016

Start date 1 July 2016

End date 31 December 2017

Funded under

• EXCELLENT SCIENCE - European Research Council (ERC)

Total cost

€ 149 375,00

EU contribution

€ 149 375,00

Coordinated by

UNIVERSITE CATHOLIQUE DE LOUVAIN
Belgium

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (2)

A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice

Author(s): Hubert Plovier, Amandine Everard, Céline Druart, Clara Depommier, Matthias Van Hul, Lucie Geurts, Julien Chilloux, Noora Ottman, Thibaut Duparc, Laeticia Lichtenstein, Antonis Myridakis, Nathalie M Delzenne, Judith Klievink, Arnab Bhattacharjee, Kees C H van der Ark, Steven Aalvink, Laurent O Martinez, Marc-Emmanuel Dumas, Dominique Maiter, Audrey Loumaye, Michel P Hermans, Jean-Paul Thissen, Cla
Published in: Nature Medicine, Issue 23/1, 2016, Page(s) 107-113, ISSN 1078-8956
Publisher: Nature Publishing Group
DOI: 10.1038/nm.4236

Interactions between gut microbes and host cells control gut barrier and metabolism

Author(s): P D Cani
Published in: International Journal of Obesity Supplements, Issue 6/S1, 2016, Page(s) S28-S31, ISSN 2046-2166
Publisher: Nature Publishing Group
DOI: 10.1038/ijosup.2016.6